Drugs / AHSG
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02922816 | Dec 2016 → Dec 2021 | bacterial infectious disease | Emory University | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AHSG | “The Fecal Microbiota Transplant (FMT) using Allogeneic human stool in glycerol (10%) (AHSG) intervention” NCT02922816 ↗ |
| Route | Rectal | “administered via rectal retention enema” NCT02922816 ↗ |